Inita Buliņa
Inita Buliņa publishes mostly in Rheumatology, Infectious Diseases and Hematology, on topics such as Rheumatoid Arthritis Research and Therapies, SARS-CoV-2 and COVID-19 Research and COVID-19 Clinical Research Studies.
- World rank
- #926,811 of 7,710,434 ranked researchers
- Rank in Latvia
- #72 of 4,070
- Works
- 33
- Citations
- 823
- Citations per work
- 24.9
What does Inita Buliņa research?
Inita Buliņa's work is mostly in Medicine (67%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2267.0%
- Medicine2267.0%
- Everything else1133.0%
- 1Rheumatology23% of their works
- 2Infectious Diseases22% of their works
- 3Hematology7% of their works
- 4Epidemiology6% of their works
- 5Pulmonary and Respiratory Medicine4% of their works
- 6Pathology and Forensic Medicine3% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Autoimmune and Inflammatory Disorders Research
- Inflammatory Myopathies and Dermatomyositis
- Systemic Lupus Erythematosus Research
- Dermatological and COVID-19 studies
- Systemic Sclerosis and Related Diseases
Which keywords describe Inita Buliņa's research?
The keywords of their largest research topics: Autoantibodies, ACE2 Receptor, SARS-CoV-2, Inflammation, Rheumatoid Arthritis, Clinical Characteristics, Coronavirus and Epidemiology.
- Systemic Sclerosis
- Dermatologic Manifestations
- Systemic Lupus Erythematosus
- Inflammatory Myopathies
- Juvenile Idiopathic Arthritis
- Treatment
- Epidemiology
- Clinical Characteristics
- Inflammation
- ACE2 Receptor
- Autoantibodies
- SARS-CoV-2
- Rheumatoid Arthritis
- Coronavirus
- Vaccine
- Hemophagocytic Lymphohistiocytosis
- Dermatomyositis
- Antiphospholipid Syndrome
- COVID-19
- Fibrosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Autoantibodies274 topics
- ACE2 Receptor202 topics
- SARS-CoV-2202 topics
- Inflammation151 topic
- Rheumatoid Arthritis151 topic
- Clinical Characteristics101 topic
- Coronavirus101 topic
- Epidemiology101 topic
- Vaccine101 topic
- Treatment82 topics
- Hemophagocytic Lymphohistiocytosis71 topic
- Juvenile Idiopathic Arthritis71 topic
- Dermatomyositis51 topic
- Inflammatory Myopathies51 topic
- Antiphospholipid Syndrome41 topic
- Systemic Lupus Erythematosus41 topic
- COVID-1931 topic
- Dermatologic Manifestations31 topic
- Fibrosis31 topic
- Systemic Sclerosis31 topic
Where does Inita Buliņa work?
Inita Buliņa's main affiliation in the publication record is Pauls Stradiņš Clinical University Hospital, Latvia.
How many publications and citations does Inita Buliņa have?
OpenAlex counts 33 works and 823 citations for Inita Buliņa, an h-index of 12, ranking #926,811 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Inita Buliņa. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.